IESE (España)
-
New Immuno-Oncology Solutions (NIOS): Aligning Stakeholders in the Biotech Industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacCase SM-1701-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €8.20
-
bnc10: An Alternative to Traditional Banking
Antón, Miguel; Giné, Mireia; de la Peña, Juan Vidal; Llorens AlbertCase F-969-EEconomics, FinanceNew round of financing for a recently born NeobankStarting at €8.20
-
Investing in Bitcoin
Antón, Miguel; Giné, Mireia; de la Peña, Juan VidalCase F-968-EFinanceStarting at €8.20
-
New Immuno-Oncology Solutions (NIOS) - Teaching Note: Aligning stakeholders in the biotech industry
Vroom, Govert; Maribel Berges; Sastre Boquet, IsaacTeaching Note SMT-136-EEntrepreneurship, Innovation and Change, StrategyThis case focuses on a small biotech company (NIOS), located in Barcelona, Spain, that is developing a new immune-oncology product for treating pancreatic cancer. The drug that the company is developing has recently finished Phase I of clinical trials successfully and is now preparing for Phase II and III. At this point, the CEO is approached by her former PhD director, a university professor, who asks if the company is interested in licensing a ...Starting at €0.00
-
Invertir en el bitcoin
Antón, Miguel; Giné, Mireia; de la Peña, Juan VidalCase F-968FinanceTras casi diez meses de confinamientos intermitentes por la pandemia de covid, una gestora de hedge funds de Barcelona recibe una llamada del mayor inversor de un fondo de 480 millones de euros. El fondo, que históricamente ha tenido un gran comportamiento, lleva tres meses muy malos. Contrariado porque sus amigos presumen de no haber perdido ni un céntimo gracias a su exposición a las criptomonedas y la gestora no ha invertido todavía en el bitc...Starting at €8.20